First Time Loading...

10X Genomics Inc
NASDAQ:TXG

Watchlist Manager
10X Genomics Inc Logo
10X Genomics Inc
NASDAQ:TXG
Watchlist
Price: 27.48 USD 4.53% Market Closed
Updated: May 5, 2024

10X Genomics Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

10X Genomics Inc
Operating Income Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
10X Genomics Inc
NASDAQ:TXG
Operating Income
-$270m
CAGR 3-Years
20%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Income
$7.3B
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Operating Income
$9.5B
CAGR 3-Years
20%
CAGR 5-Years
26%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Operating Income
$1.1B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Operating Income
$1.3B
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
16%
IQVIA Holdings Inc
NYSE:IQV
Operating Income
$2.1B
CAGR 3-Years
38%
CAGR 5-Years
21%
CAGR 10-Years
16%

See Also

What is 10X Genomics Inc's Operating Income?
Operating Income
-270m USD

Based on the financial report for Mar 31, 2024, 10X Genomics Inc's Operating Income amounts to -270m USD.

What is 10X Genomics Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-22%

Over the last year, the Operating Income growth was -52%. The average annual Operating Income growth rates for 10X Genomics Inc have been 20% over the past three years , -22% over the past five years .